Margate, United Kingdom

Andrew Peter Cridland

This inventor holds 3 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Antabio Sas. Active years: 2021-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrew Peter Cridland. Retrieved from https://idiyas.com/inventor/andrew-peter-cridland-uqvg89to

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 10.6

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: **Andrew Peter Cridland: Innovator in Antibacterial Treatments**

Introduction

Andrew Peter Cridland is an accomplished inventor based in Margate, Kent, GB. With a total of three patents to his name, he has made significant contributions to the field of pharmaceutical innovations, particularly in the treatment of bacterial infections. His work continues to impact the medical community through advanced therapeutic solutions.

Latest Patents

Cridland's latest patents focus on indane derivatives designed for treating bacterial infections. The invention involves an indane compound that is characterized by a specific formula, which includes various defined components such as R, L, n, and p. These compounds can serve as either stand-alone antibiotics or work effectively in combination with other antibiotic treatments, showcasing Cridland’s role in developing vital medical therapies.

Career Highlights

Currently, Andrew Peter Cridland is affiliated with Antabio SAS, a company known for its innovative research in antibacterial treatments. His work at Antabio SAS emphasizes the importance of developing new antibiotic solutions in the fight against resistant bacterial strains. The recognition of his patents exemplifies his expertise and commitment to improving healthcare through innovation.

Collaborations

Throughout his career, Cridland has collaborated with professionals like Simon Leiris and David Thomas Davies. These partnerships enhance the research dynamics at Antabio SAS, fostering a collaborative environment that encourages the exchange of innovative ideas and methodologies in pharmaceutical development.

Conclusion

Andrew Peter Cridland represents a pioneering figure in the area of antibacterial treatments. With his innovative efforts and collaborative spirit, he continues to contribute significantly to the field of medicine, paving the way for new advancements in the treatment of bacterial infections. His work not only showcases his inventiveness but also highlights the crucial role of research and development in addressing healthcare challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…